|
WALTHAM, Mass. (December 11, 2006) — T3 Advisors, a full-service real estate brokerage and consulting firm for corporations focused on the innovation economy, today announced that they have secured a 10,679 square foot lease for Creganna, a medical device firm headquartered in Ireland. The company’s new production facility is located at 450 Donald Lynch Blvd. in Marlborough.
Greg Hoffmeister, principal of T3 Advisors, represented Creganna. Paul Leone of Richards Barry Joyce & Partners represented the landlord, Cross Harbor.
“With our company headquartered in Ireland, we relied heavily on T3 Advisors to guide and advise us through the intricacies of the US real estate market during our facility search,” said Jack Clarke, prototype centre manager of Creganna. “T3 was instrumental in locating the proper facility in Massachusetts that will help fuel our continued growth in the US market.”
Creganna Medical Devices provides leading edge technologies to minimally invasive medical device companies. Creganna provides catheter shaft components, sub-assemblies and design in a range of metals, polymers and composite materials. Creganna is a trusted supplier to the world’s leading medical device manufacturers. Creganna is headquartered in Galway, Ireland and has sales and production facilities in Massachusetts, Minnesota, California and Finland. Creganna is Ireland’s largest indigenous company in this sector. www.creganna.com
|
